Medications and Pregnancy: Navigating Prescriptions as a Physician

Managing medications during pregnancy requires individualized risk-benefit assessments that weigh the dangers of untreated conditions against potential fetal exposure. The lowest effective dose, gestational timing, and evidence-based resources form the foundation of safe prescribing. With a structured clinical framework, providers can support both maternal and fetal health with confidence.

The safest option for a pregnant patient is always to stop her medications. There is a widespread belief that stopping all medications during pregnancy is the safest option. This is not always true and physicians should feel confident having these conversations with patients to ensure proper maternal and fetal wellbeing.

Untreated depression raises the risk of preterm birth, low birth weight, obstetrical complications, and long term neurodevelopmental issues. When providers default to avoidance, the risks don't disappear; they shift. Managing medications during pregnancy means making a deliberate, informed choice between two sets of real consequences, and that decision deserves better than reflexive caution.

Key Principles of Prescribing Medications During Pregnancy

Medication safety in pregnancy starts with a few foundational rules that apply across nearly every clinical scenario. The goal is to control symptoms with the lowest effective dose for the shortest duration possible, reviewing all medications at each visit to keep total fetal exposure as low..

Polypharmacy is a very real concern. Asking patients about every prescription, over-the-counter product, and supplement they take (not just what you prescribed) gives you a clearer picture of what the fetus is actually exposed to.

Shared decision-making is a core part of this process, and starting that conversation before conception actually makes high-stakes prenatal decisions easier to handle.

How Does Gestational Timing Affect Medication Decisions?

Timing matters significantly in pregnancy prescribing, and the risk profile of any given medication shifts by trimester. The first trimester covers organogenesis, making it the period of highest sensitivity to drug exposure.

Later trimesters bring a different set of clinical concerns. Pregnancy changes how the body processes drugs. For example, plasma volume increases, renal clearance rises, and hepatic metabolism accelerates.

Higher doses of some medications may be needed in the second and third trimesters to maintain a therapeutic effect. Neonates exposed to certain medications late in pregnancy may require monitoring for withdrawal or adaptation symptoms after birth.

Conducting a Risk-Benefit Assessment

Physician guidelines for pregnancy prescribing center on one core question: What is the greater risk? Treating or not treating? Untreated depression, for instance, is linked to preterm birth, poor prenatal care, and postpartum complications.

Maternal health and medications have a bidirectional relationship; the condition itself carries fetal risk, and so does drug exposure.

The FDA updated its labeling system in 2015, replacing the A-X category system with narrative summaries that are more clinically useful. These summaries cover pregnancy exposure registry data, known risks, and specific clinical considerations for each drug. Providers should consult current databases alongside ACOG bulletins when making prescribing decisions.

Common Medications and Their Safety Profiles

Safe prescriptions during pregnancy exist across most common clinical categories, and knowing which options have solid evidence behind them makes decision-making more efficient. Acetaminophen remains the first-line choice for pain and fever management per ACOG guidance, with no established causal link to neurodevelopmental harm.

Here are some commonly used medications with established safety profiles in pregnancy:

• Penicillins and erythromycin are generally accepted as safe antibiotic options
• Diphenhydramine is an acceptable choice for cold and allergy symptom relief
• Guaifenesin is typically used for congestion relief after the first trimester
• SSRIs are often continued in pregnancy when the risks of untreated depression are significant
• NSAIDs are typically avoided after the first trimester

When Should You Refer to a Specialist?

Some clinical situations call for more than a database lookup, and recognizing those triggers early leads to better outcomes for mother and baby.

Complex polypharmacy, newly prescribed high-risk medications, and psychiatric conditions that are hard to stabilize are all pretty clear indicators for maternal-fetal medicine. Referring to a psychiatrist, or reproductive psychiatrist if available, is appropriate if a patient has complex mental health issues or is not responding to medications already prescribed. Multidisciplinary input is very often what keeps a complex case manageable rather than escalating.

Knowing when to bring in a specialist is a significant part of pregnancy drug safety tips for any prescribing provider. Some common referral triggers include:

• A patient starting a new medication with limited pregnancy safety data
• Polypharmacy cases involving three or more concurrent prescriptions
• Psychiatric conditions requiring dose adjustments across trimesters
• Neonatal monitoring concerns identified at a prenatal visit

For Kentucky providers, KyCOMPASS offers free, near real-time peer-to-peer psychiatric consultation with licensed clinicians and perinatal psychiatry specialists, so complex prescribing questions around mental health and substance use get answered quickly, without waiting on a formal referral process.

Frequently Asked Questions

Can a Patient Continue Psychiatric Medications If She Becomes Pregnant Unexpectedly?

In many cases, yes, and abrupt discontinuation can actually trigger relapse. The risks of untreated psychiatric illness in pregnancy are well-documented, so the decision should be made collaboratively with the patient and, where possible, a specialist, so that all the evidence is on the table before any change is made.

Are Herbal Supplements and Over-the-Counter Vitamins Safe During Pregnancy?

Some herbal supplements carry uterotonic or hormonal effects that pose real fetal risk. Providers should review all supplements at every prenatal visit and consult a reliable drug database when uncertain. A product being labeled "natural" does not make it safe during pregnancy.

How Should Providers Document Medication Decisions Made During Pregnancy?

Documentation should reflect the risk-benefit discussion held with the patient, the evidence consulted, and the patient's role in the final decision. Recording the clinical rationale, including which specific resources were reviewed, protects both the patient and the provider if outcomes are questioned later.

Are There Medications Commonly Avoided in Pregnancy That Are Actually Safe?

Yes, actually. Some medications carry a historical reputation for risk that more recent research has not supported at all. Consulting current databases rather than relying on older categorical guidance gives providers a more accurate, up-to-date picture of what the evidence really shows.

Put Evidence-Based Prescribing Into Practice

Safe, evidence-based prescribing of medications during pregnancy is a clinical skill built on risk-benefit analysis, gestational awareness, and access to reliable resources. This article has outlined the key principles, from FDA labeling changes to specialist referral triggers, that help providers make informed, confident decisions for their patients.

Kentucky providers have a dedicated resource in KyCOMPASS: a free program offering near real-time peer-to-peer psychiatric consultation with licensed clinicians and perinatal psychiatry specialists who review your specific case and respond within business hours. Place a consult today and get the individualized guidance your patients need.

For those looking to learn more, trusted resources like MotherToBaby.org, Reprotox.org, and LactMed can offer additional guidance and support.